Insights

The COVID-19 pandemic is pushing China, as with countries around the world, towards a higher level of digitalization, transforming sectors like traditional retail, tourism, education, and other industries that mainly rely on offline operations. Boosted digitalization demand after the outbreak and people’s increasing dependence on...

US electric vehicle (EV) maker Tesla [TSLA:US] recently filed a product recall plan with China’s State Administration for Market Regulation (SAMR), as reported by People.cn on October 26. The carmaker plans to recall a portion of its imported Model S and Model X cars, totaling...

The Guangzhou Development District recently launched a green finance service platform, as reported by Eastmoney on October 26. The platform is a comprehensive system consisting of green finance-related policy briefings, as well as disclosure of green projects and enterprise applications. The platform aims to facilitate...

On September 4, Shenzhen Stock Exchange (SZSE) revised measures for reviewing information disclosure of companies listed on the bourse, in an attempt to further boost company quality. Under the new measures, Shenzhen authorities for the first time added environmental, social, and governance (ESG) performance disclosure...

China’s practices on social responsibility investment ESG, which stands for environmental, social, and governance, is a long-term growth investment strategy that focuses on the non-financial performance of a company. The core of ESG-themed investment is to explore a sustainable development path that finds a balance between...

What Motivates Investors to Use ESG Data? The UN-PRI was one of the initial large-scale organizations to put forth the concept of ESG, and from 2005, the idea has gained traction globally. Since then, an increasing number of institutions have ascribed to the idea, and by...

Changsheng Bio-Technology fabricates vaccine data Changsheng Bio-Technology, based in Changchun, Jilin Province, used to be one of the largest vaccine-makers in China. By the end of 2017, the firm had six vaccine products, produced by its main subsidiary, Changchun Changsheng. From 2015 to 2017, the company’s...

en_USEnglish